Search Results

There are 122927 results for: content related to: Mutations in the interferon sensitivity-determining region (nonstructural 5A amino acid 2209–2248) in patients with hepatitis C-1b infection and correlating response to combined therapy of pegylated interferon and ribavirin

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Article first published online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  3. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Article first published online : 24 SEP 2008, DOI: 10.1002/hep.22645

  4. Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: 280–286, K. Hayashi, Y. Katano, M. Ishigami, A. Itoh, Y. Hirooka, I. Nakano, F. Urano, K. Yoshioka, H. Toyoda, T. Kumada and H. Goto

    Article first published online : 28 MAR 2010, DOI: 10.1111/j.1365-2893.2010.01305.x

  5. You have free access to this content
    Review article: specifically targeted anti-viral therapy for hepatitis C – a new era in therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 1, July 2010, Pages: 14–28, C. M. Lange, C. Sarrazin and S. Zeuzem

    Article first published online : 31 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04317.x

  6. IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma

    Journal of Viral Hepatitis

    Volume 18, Issue 10, October 2011, Pages: e550–e560, T. Kawaoka, H. Aikata, S. Takaki, A. Hiramatsu, K. Waki, N. Hiraga, D. Miki, M. Tsuge, M. Imamura, Y. Kawakami, S. Takahashi, H. Ochi, H. Tashiro, H. Ohdan and K. Chayama

    Article first published online : 23 MAY 2011, DOI: 10.1111/j.1365-2893.2011.01468.x

  7. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Article first published online : 1 OCT 2014, DOI: 10.1002/hep.27533

  8. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents

    Journal of Viral Hepatitis

    Volume 19, Issue 7, July 2012, Pages: 449–464, F. Poordad and D. Dieterich

    Article first published online : 7 JUN 2012, DOI: 10.1111/j.1365-2893.2012.01617.x

  9. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Article first published online : 30 SEP 2013, DOI: 10.1002/phar.1349

  10. Hepatitis C virus: The role of molecular mimicry in response to interferon treatment

    Journal of Medical Virology

    Volume 84, Issue 10, October 2012, Pages: 1571–1585, Samra Uzicanin, Yu-Wen Hu, Husam Alsousi, Martin Pelchat, Lynda Rocheleau, Rama C. Nair and Earl G. Brown

    Article first published online : 15 AUG 2012, DOI: 10.1002/jmv.23361

  11. Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28B

    Hepatology Research

    Volume 43, Issue 6, June 2013, Pages: 580–588, Kazuhiko Hayashi, Yoshiaki Katano, Hiroko Masuda, Youji Ishizu, Teiji Kuzuya, Takashi Honda, Masatoshi Ishigami, Akihiro Itoh, Yoshiki Hirooka, Isao Nakano, Tetsuya Ishikawa, Fumihiro Urano, Kentaro Yoshioka, Hidenori Toyoda, Takashi Kumada and Hidemi Goto

    Article first published online : 29 JAN 2013, DOI: 10.1111/hepr.12005

  12. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Article first published online : 19 SEP 2007, DOI: 10.1002/hep.22017

  13. You have free access to this content
    Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy

    Microbiology and Immunology

    Volume 55, Issue 6, June 2011, Pages: 418–426, Ahmed El-Shamy, Ikuo Shoji, Takafumi Saito, Hisayoshi Watanabe, Yoshi-Hiro Ide, Lin Deng, Sumio Kawata and Hak Hotta

    Article first published online : 29 MAY 2011, DOI: 10.1111/j.1348-0421.2011.00331.x

  14. Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 1, January 2015, Pages: 178–183, Kazuhiko Hayashi, Yoshiaki Katano, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Masatoshi Ishigami, Akihiro Itoh, Yoshiki Hirooka, Tetsuya Ishikawa, Isao Nakano, Kentaro Yoshioka, Hidenori Toyoda, Takashi Kumada and Hidemi Goto

    Article first published online : 23 DEC 2014, DOI: 10.1111/jgh.12673

  15. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  16. Reappraisal of the importance of mutations in the NS5A-PKR-binding domain of hepatitis C-1b virus in the era of optimally individualized therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 2, February 2011, Pages: 119–128, T.-M. Chen, P.-T. Huang, C.-F. Wen, J.-N. Tung, K.-C. Chow and Y.-P. Chen

    Article first published online : 2 MAR 2010, DOI: 10.1111/j.1365-2893.2010.01287.x

  17. Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin

    Journal of Viral Hepatitis

    Volume 10, Issue 2, March 2003, Pages: 87–94, C.-H. Hung, C.-M. Lee, S.-N. Lu, J.-F. Lee, J.-H. Wang, H.-D. Tung, T.-M. Chen, T.-H. Hu, W.-J. Chen and C.-S. Changchien

    Article first published online : 4 MAR 2003, DOI: 10.1046/j.1365-2893.2003.00414.x

  18. Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e117–e125, K. Kumthip, C. Pantip, P. Chusri, S. Thongsawat, A. O’Brien, K. E. Nelson and N. Maneekarn

    Article first published online : 19 OCT 2010, DOI: 10.1111/j.1365-2893.2010.01379.x

  19. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Article first published online : 1 OCT 2014, DOI: 10.1002/hep.27516

  20. You have free access to this content
    Review article: investigational agents for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 29, Issue 7, April 2009, Pages: 689–705, A. J. V. THOMPSON and J. G. MCHUTCHISON

    Article first published online : 17 JAN 2009, DOI: 10.1111/j.1365-2036.2009.03927.x